XOMA Royalty (XOMA) Capital Expenditures Growth (3y) (2013 - 2017)
XOMA Royalty (XOMA) Capital Expenditures Growth (3y) (2013 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.48 Mn |
-60.60 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2017 |
-29.33% |
| Dec 31, 2016 |
-34.58% |
| Mar 31, 2016 |
-60.37% |
| Dec 31, 2015 |
-27.80% |
| Sep 30, 2015 |
-60.53% |
| Jun 30, 2015 |
-31.90% |
| Mar 31, 2015 |
-25.68% |
| Dec 31, 2014 |
-48.51% |
| Sep 30, 2014 |
-23.86% |
| Jun 30, 2014 |
-71.68% |
| Mar 31, 2014 |
-61.93% |
| Dec 31, 2013 |
17.27% |
| Sep 30, 2013 |
109.01% |
